Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
4d Molecular Therapeutics Inc. (FDMT)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 49,340,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   4D Molecular Therapeutics is a clinical-stage gene therapy company engaging the development of product candidates using its targeted and evolved adeno-associated viruses vectors. Co. has built a portfolio of gene therapy product candidates, with five product candidates in clinical trials: 4D-125 for the treatment of X-linked retinitis pigmentosa, 4D-150 for the treatment of wet age-related macular degeneration, 4D-110 for the treatment of choroideremia, 4D-310 for the treatment of Fabry disease, and 4D-710 for the treatment of cystic fibrosis lung disease.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 850,000
Total Buy Value $0 $0 $0 $13,600,000
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 21,145 791,941 797,938 955,783
Total Sell Value $668,973 $16,684,699 $16,804,030 $20,280,103
Total People Sold 1 4 4 5
Total Sell Transactions 6 15 17 27
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 66
  Page 3 of 3  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Schaffer David Director   –       •      –    2021-09-30 4 AS $26.69 $333,250 D/D (12,385) 937,500     -
   Schaffer David Director   –       •      –    2021-09-29 4 AS $27.99 $482,614 D/D (16,871) 949,885     -
   Schaffer David Director   –       •      –    2021-09-28 4 AS $30.52 $424,693 D/D (13,912) 966,756     -
   Schaffer David Director   –       •      –    2021-09-27 4 AS $32.59 $635,826 D/D (19,332) 980,668     -
   Moretti August J Chief Financial Officer   •       –      –    2021-04-12 4 OE $9.41 $9,410 D/D 1,000 2,000     -
   Yao Tony Dung Ling Director   –       •      –    2020-12-15 4 B $23.00 $9,775,000 I/I 425,000 1,060,880 2.1     -
   Yao Tony Dung Ling Director   –       •      –    2020-12-15 4 A $0.00 $0 I/I 635,880 635,880     -
   Yao Tony Dung Ling Director   –       •      –    2020-12-15 4 A $0.00 $0 D/D 2,864 2,864     -
   Milligan John F Director   –       •      –    2020-12-15 4 B $23.00 $2,300,000 I/I 100,000 100,000 2.1     -
   Kamal Fariborz See Remarks   •       –      –    2020-12-15 4 B $23.00 $99,981 D/D 4,347 4,347 2.74     -
   Shabet Rose Sharon 10% Owner   –       –       •   2020-12-15 4 B $23.00 $25,300,000 I/I 1,100,000 3,937,914 1.5     -
   Shabet Rose Sharon 10% Owner   –       –       •   2020-12-15 4 A $0.00 $0 I/I 2,837,914 2,837,914     -
   Schaffer David Director   –       •       •   2020-12-10 3 IO $0.00 $0 I/I 0 2,000,000     -
   Moretti August J See RemarksOfficer   •       –      –    2020-12-10 3 IO $0.00 $0 D/D 0 1,000     -
   Kirn David See RemarksOfficer   •       •       •   2020-12-10 3 IO $0.00 $0 D/D 0 2,000,000     -
   Theuer Charles Director   –       •      –    2020-12-10 3 IO $0.00 $0 D/D 0 32,351     -

  66 Records found
  1  2  3    
  Page 3 of 3
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed